Willow Biosciences (TSE:WLLW) Reaches New 52-Week Low – Time to Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report)’s share price hit a new 52-week low during trading on Monday . The company traded as low as C$0.06 and last traded at C$0.06, with a volume of 160000 shares changing hands. The stock had previously closed at C$0.06.

Willow Biosciences Stock Performance

The company has a debt-to-equity ratio of 131.61, a quick ratio of 19.71 and a current ratio of 0.70. The company has a market capitalization of C$8.65 million, a price-to-earnings ratio of -1.00 and a beta of 1.13. The firm has a 50-day simple moving average of C$0.08 and a two-hundred day simple moving average of C$0.09.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc, a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation.

Further Reading

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.